Filter
66
Filtered Results: 66
Text search:
prevalence
of
myopia
Featured
Recommendations
10
New Publications
26
Language
Document type
No document type
42
Guidelines
12
Studies & Reports
6
Manuals
3
Strategic & Response Plan
2
Fact sheets
1
Countries / Regions
India
7
Kenya
4
Nepal
3
West and Central Africa
3
Malawi
2
Global
2
Bangladesh
2
Namibia
2
Ethiopia
2
Sierra Leone
1
Rwanda
1
Cameroon
1
Nigeria
1
Burkina Faso
1
Philippines
1
Cambodia
1
Latin America and the Carribbean
1
Middle East and North Africa
1
East and Southern Africa
1
Uganda
1
Zambia
1
Indonesia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
14
Guidelines
13
Dental & Eye Care
4
HIV & STI
4
Paediatrics
3
Pediatrics
3
Policies
3
Hemorrhagic Fever
2
Studies & Reports
2
Capacity Building
2
Countries
1
Chagas
1
NCD
1
Drugs & Medical Equipment
1
Women & Child Health
1
Community Health
1
Disabilities
1
Respiratory Infections
1
Gynaecology & Obstetrics
1
Maternal Health
1
Non-communicable Diseases
1
Age & Elderly
1
Neonatal Care
1
Disease Prevention & Control
1
Toolboxes
Vision Loss & Blindness
5
Long COVID/ Post-COVID Syndrome
3
Antiretroviral Treatment ART
3
Clinical Aspects, Treatment & Prevention
2
Clinical Aspects
2
Treatment Guidelines
2
Clinical Guidelines
2
General
2
Neurological disorders, Others
2
Alcohol
1
Treatment & Prevention
1
Studies & Reports
1
Key Resources
1
Interculturality
1
Studies & Reports
1
Advocacy
1
Training, others
1
Oxygen Therapy
1
Agriculture
1
Rational use of Medicine
1
General documents One Health
1
Pharmacovigilance
1
Mental Disorders
1
Zoonoses
1
Chagas
1
Overview, Studies & Reports
1
Education
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
General Aspects
1
Bipolar Affective Disorders
1
Policy
1
Anxiety Disorders
1
Depression
1
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
Transforming Health: Accelerating attainment of Health Goals | THE SECOND MEDIUM TERM PLAN FOR HEALTH
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Washington (DC): National Academies Press (US); 2001.
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
Wet markets have been implicated in multiple zoonotic outbreaks, including COVID-19. They are also a conduit for legal and illegal trade in wildlife, which threatens thousands of species. Yet wet markets supply food to millions of people around the world, and differ drastically in their physical com...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Glaucoma is a leading cause of irreversible blindness globally. In Malawi, glaucoma accounts for 15.8% of the blindness among people aged 50 years and above. Blindness from glaucoma is preventable with early detection and timely treatment. However, glaucoma management remains a challenge to eye care...
